Tarsus Pharmaceuticals
TARS
TARS
162 hedge funds and large institutions have $1.43B invested in Tarsus Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 39 funds opening new positions, 58 increasing their positions, 42 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
162
Holders Change
+14
Holders Change %
+9.46%
% of All Funds
2.34%
Holding in Top 10
8
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+100%
% of All Funds
0.12%
New
39
Increased
58
Reduced
42
Closed
25
Calls
$17.5M
Puts
$135K
Net Calls
+$17.4M
Net Calls Change
+$37.1M
Top Buyers
| 1 |
Jennison Associates
New York
|
$71.7M |
| 2 |
BlackRock
New York
|
$124M |
| 3 |
JPMorgan Chase & Co
New York
|
$14.5M |
| 4 |
Morgan Stanley
New York
|
$72.6M |
| 5 |
ABG
Ally Bridge Group
New York
|
$10.6M |
